Does allergen immunotherapy alter the natural course of allergic disorders? (Q34212909)

31 July 2017

1 reference

title

Does allergen immunotherapy alter the natural course of allergic disorders? (English)

1 reference

31 July 2017

1 reference

Yang X

1

1 reference

31 July 2017

publication date

1 January 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

61

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

365-374

1 reference

Immunological mechanisms operative in allergen-specific immunotherapy

31 July 2017

cites work

1 reference

12 December 2020

Regulation of IgE and IgG4 synthesis in patients with hyper IgE syndrome

1 reference

12 December 2020

Early modifications of chemokine production and mRNA expression during rush venom immunotherapy.

1 reference

12 December 2020

Diagnosis and immunotherapy of mould allergy. V. Clinical efficacy and side effects of immunotherapy with Cladosporium herbarum

1 reference

12 December 2020

Long-term follow-up of patients treated with a three-year course of cat or dog immunotherapy

1 reference

12 December 2020

Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation

1 reference

12 December 2020

IgE and IgG subclass regulation by IL-4 and IFN-gamma in human helminth infections. Assessment by B cell precursor frequencies

1 reference

12 December 2020

Sub-class of IgG anti-bee venom antibody produced during bee venom immunotherapy and its relationship to long-term protection from bee stings and following termination of venom immunotherapy.

1 reference

12 December 2020

Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.

1 reference

12 December 2020

Mechanisms of specific immunotherapy of allergic diseases

1 reference

12 December 2020

In vitro studies of human ragweed allergy: changes in cellular and humoral activity associated with specific desensitization

1 reference

12 December 2020

A controlled trial of immunotherapy for asthma in allergic children

1 reference

12 December 2020

Grass pollen immunotherapy: efficacy and safety during a 4-year follow-up study

1 reference

12 December 2020

Immunotherapy with grass pollen major allergens. Immunological results from a prospective 3-year double blind study

1 reference

12 December 2020

IL-10 deficiency prevents IL-5 overproduction and eosinophilic inflammation in a murine model of asthma-like reaction

1 reference

12 December 2020

Allergic rhinitis and asthma: how important is the link?

1 reference

12 December 2020

The kinetics of change in cytokine production by CD4 T cells during conventional allergen immunotherapy

1 reference

12 December 2020

Prospective study on immunologic changes induced by two different Dermatophagoides pteronyssinus extracts prepared from whole mite culture and mite bodies

1 reference

12 December 2020

Significant correlation between symptom score and IgG4 antibody titer following long-term immunotherapy for perennial allergic rhinitis

1 reference

12 December 2020

IgG subclass antibody response in grass pollen-allergic patients undergoing specific immunotherapy. Prognostic value of serum IgG subclass antibody levels early in immunotherapy

1 reference

12 December 2020

Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials

1 reference

12 December 2020

Quantitation of antigen-specific immunoglobulin G in human serum. II. Comparison of radioimmunoprecipitation and solid-phase radioimmunoassay techniques for measurement of immunoglobulin G specific for a complex allergen mixture (yellow jacket venom

1 reference

12 December 2020

Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals

1 reference

12 December 2020

Natural history of insect sting allergy: relationship of severity of symptoms of initial sting anaphylaxis to re-sting reactions

1 reference

12 December 2020

Corticosteroids restore the balance between locally produced Th1 and Th2 cytokines and immunoglobulin isotypes to normal in sarcoid lung

1 reference

12 December 2020

Follow-up after systemic adverse reactions of immunotherapy

1 reference

12 December 2020

The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients

1 reference

12 December 2020

The natural history of IgE sensitisation and atopic disease in early childhood

1 reference

12 December 2020

Insect venom allergy: Diagnosis and treatment

1 reference

12 December 2020

The natural history of Apis-specific IgG and IgG4 in beekeepers.

1 reference

12 December 2020

Immunotherapy and mast cell activation

1 reference

12 December 2020

Clinical efficacy of specific immunotherapy to cat dander: a double-blind placebo-controlled trial

1 reference

12 December 2020

IgG subclass antibodies in response to house dust mite immunotherapy

1 reference

12 December 2020

SEROLOGICAL EVIDENCE OF IMMUNITY WITH COEXISTING SENSITIZATION IN A TYPE OF HUMAN ALLERGY (HAY FEVER).

1 reference

12 December 2020

Seasonal asthma in northern California: allergic causes and efficacy of immunotherapy.

1 reference

12 December 2020

Immunotherapy with partially purified and standardized tree pollen extracts. IV. Results from long-term (6-year) follow-up

1 reference

12 December 2020

Patient satisfaction and allergen immunotherapy

1 reference

12 December 2020

A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. I. Clinical results

1 reference

12 December 2020

The expanding universe of T-cell subsets: Th1, Th2 and more.

1 reference

12 December 2020

Natural course of asthma and allergy in childhood

1 reference

12 December 2020

Effect of immunotherapy on the production of eosinophil adhesion-inducing activity from mononuclear cells in house-dust-mite-sensitive bronchial asthma

1 reference

12 December 2020

Newly generated IgE antibodies to Dermatophagoides pteronyssinus in children are directed against components distinct from Der p I and Der p II

1 reference

12 December 2020

A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: clinical efficacy and side effects

1 reference

12 December 2020

Long-term clinical efficacy of grass-pollen immunotherapy

1 reference

12 December 2020

Immunotherapy with yellow jacket venom. A comparative study including three different extracts, one adsorbed to aluminium hydroxide and two unmodified

1 reference

12 December 2020

Does the effect of immunotherapy last after termination of treatment? Follow-up study in patients with grass pollen rhinitis

1 reference

12 December 2020

Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs

1 reference

12 December 2020

Development of immunoglobulins to venoms during specific immunotherapy

1 reference

12 December 2020

A double-blind, randomized study investigating the efficacy and specificity of immunotherapy with Artemisia vulgaris or Phleum pratense/betula verrucosa

1 reference

12 December 2020

Bee venom immunotherapy induces a shift in cytokine responses from a TH-2 to a TH-1 dominant pattern: comparison of rush and conventional immunotherapy

1 reference

12 December 2020

Clustered immunotherapy with Yellow Jacket venom. Evaluation of the influence of time interval on in vivo and in vitro parameters.

1 reference

12 December 2020

Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures

1 reference

12 December 2020

Systemic reactions due to allergen immunotherapy

1 reference

12 December 2020

Allergen-specific modulation of cytokine synthesis patterns and IgE responses in vivo with chemically modified allergen.

1 reference

12 December 2020

Allergen-driven limiting dilution analysis of human IL-4 and IFN-gamma production in allergic rhinitis and clinically tolerant individuals

1 reference

12 December 2020

Therapeutic effects of preferential induction of mite-specific T helper 0 clones

1 reference

12 December 2020

Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors.

1 reference

12 December 2020

Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen

1 reference

12 December 2020

Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.

1 reference

12 December 2020

Immunotherapy with partially purified and standardized tree pollen extracts. III. Specific IgE response to the major allergens of alder, birch and hazel pollen during immunotherapy

1 reference

12 December 2020

Honeybee venom allergy: results of a sting challenge 1 year after stopping successful venom immunotherapy in 86 patients.

1 reference

12 December 2020

Immunotherapy as an effective tool in allergy treatment

1 reference

12 December 2020

Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children

1 reference

12 December 2020

Chemically modified antigen preferentially elicits induction of Th1-like cytokine synthesis patterns in vivo

1 reference

12 December 2020

The IgG subclasses of antibodies to grass pollen allergens produced in hay fever patients during hyposensitization

1 reference

12 December 2020

A placebo-controlled trial of immunotherapy with two extracts of Dermatophagoides pteronyssinus in allergic rhinitis, comparing clinical outcome with changes in antigen-specific IgE, IgG, and IgG subclasses

1 reference

12 December 2020

Natural history of bronchial asthma in childhood. A prospective study from birth up to 12-14 years of age

1 reference

12 December 2020

1 reference

12 December 2020

Immunotherapy for cat asthma

1 reference

12 December 2020

Monitoring allergen immunotherapy of pollen-allergic patients: the ratio of allergen-specific IgG4 to IgG1 correlates with clinical outcome

1 reference

12 December 2020

Functional diversity of helper T lymphocytes

1 reference

12 December 2020

Clinical and immunological effects of immunotherapy with alum-absorbed grass allergoid in grass-pollen-induced hay fever

1 reference

12 December 2020

The subclass nature and clinical significance of the IgG antibody response in patients undergoing allergen-specific immunotherapy

1 reference

12 December 2020

Atopic allergy and serum IgE concentrations in randomly selected children followed up from 8 to 12 years of age

1 reference

12 December 2020

Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells.

1 reference

12 December 2020

Immunotherapy with cat- and dog-dander extracts. V. Effects of 3 years of treatment

1 reference

12 December 2020

Capacity of specific immunotherapy in prevention of allergic asthma in children: the Preventive Allergy Treatment Study (PAT)

1 reference

12 December 2020

A controlled trial of immunotherapy in insect hypersensitivity

1 reference

12 December 2020

Evaluation of Hymenoptera-sting sensitivity with deliberate sting challenges: inadequacy of present diagnostic methods.

1 reference

12 December 2020

The evaluation of the common diagnostic methods of hypersensitivity for bee and yellow jacket venom by means of an in-hospital insect sting.

1 reference

12 December 2020

Systemic reactions from allergen immunotherapy

1 reference

12 December 2020

Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper

1 reference

12 December 2020

Immunotherapy of allergy: anergy, deletion, and immune deviation

1 reference

12 December 2020

Effect of IL-2 on immunoglobulin production by anti-CD40-activated human B cells: synergistic effect with IL-10 and antagonistic effect with IL-4

1 reference

12 December 2020

Specific immunotherapy downregulates peripheral blood CD4 and CD8 T-lymphocyte activation in grass pollen-sensitive asthma

1 reference

12 December 2020

Appearance of atopic disease in relation to serum IgE antibodies in children followed up from birth for 4 to 15 years

1 reference

12 December 2020

House dust mite immunotherapy results in a decrease in Der p 2-specific IFN-gamma and IL-4 expression by circulating T lymphocytes

1 reference

12 December 2020

Systemic reactions occurring during immunotherapy with standardized pollen extracts

1 reference

12 December 2020

Venom immunotherapy modulates interleukin-4 and interferon-gamma messenger RNA expression of peripheral T lymphocytes

1 reference

12 December 2020

Immunotherapy in allergy to dog: a double-blind clinical study

1 reference

12 December 2020

Long-term changes in inhalant allergy in asthmatic children

1 reference

12 December 2020

Natural history of sensitizations in atopic dermatitis. A 3-year follow-up in 250 children: food allergy and high risk of respiratory symptoms

1 reference

12 December 2020

Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students.

1 reference

12 December 2020

High IgG4 antibody level is associated with failure of immunotherapy with inhalant allergens.

1 reference

12 December 2020

Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro

1 reference

12 December 2020

Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production

1 reference

12 December 2020

10.2165/00003495-200161030-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1012240261

0 references

1 reference